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I 
摘  要 
肝细胞性肝癌（hepatocellular carcinoma, HCC），是世界上最常见的恶性肿
瘤之一，具有高度恶性、血供丰富、生长迅速及起病相对隐匿等特点。作为富血
管实体瘤，HCC 的主要特征是肿瘤细胞失控性增殖导致肿瘤内缺氧微环境的形
成，促进新生血管生成，从而促进肿瘤生长。 
姜黄素是从草本姜科植物姜黄的根茎中提取出来的一种脂溶性酚类色素，具
有抗氧化、抗炎、抗凝、降脂、抗动脉粥样硬化、抗肿瘤、抗血管生成、保护肝
功能及抗衰老消除自由基等广泛药理作用。姜黄素具有抗癌谱广、毒副作用小及
价格低廉的优点，使之成为近期的研究热点。但姜黄素抗肿瘤作用的机制复杂，
尤其抗血管生成作用的机制至今仍未彻底阐明。因此，值得深入研究姜黄素抗肿
瘤血管生成作用的机制。 
细胞信号传导系统在细胞的生理和病理过程中均发挥重要的作用，而且在与
肿瘤的发生发展密切相关。我们课题组前期的实验研究表明，胰岛素样生长因子
1 受体（Insulin-like Growth Factor Receptor-1 receptor，IGF-1R）通路与缺氧 HepG2
肝癌细胞 VEGF 的表达存在正相关性，而且姜黄素可能通过 IGF-1R 通路抑制缺
氧HepG2肝癌细胞VEGF的表达。因此，本研究通过构建 IGF-1R基因敲除HepG2
细胞模型及诱导其缺氧体外模型，来明确姜黄素是否通过 IGF-1R 通路抑制缺氧
HepG2 肝癌细胞 VEGF 的表达。 
本实验先利用CRISPR-Cas9技术简单高效地成功构建了IGF-1R基因敲除
HepG2肝癌细胞模型。以四甲基偶氮唑盐（MTT）比色法观察IGF-1R基因敲除
对HepG2肝癌细胞及姜黄素对野生型HepG2肝癌细胞和IGF-1R基因敲除HepG2
肝癌细胞存活力的影响。结果表明，IGF-1R基因敲除的HepG2肝癌细胞与野生型
相比，细胞增殖明显受抑制，凋亡增加；其次，姜黄素抑制IGF-1R基因敲除的
HepG2肝癌细胞增殖的作用要强于野生型。 
为了探讨缺氧对IGF-1R基因敲除HepG2肝癌细胞存活力和IGF-1R、HIF-1α、
VEGF表达及相关性的影响，我们利用氯化钴（CoCl2）构建缺氧模型，以MTT
比色法观察不同缺氧条件对IGF-1R基因敲除HepG2肝癌细胞存活力的影响；利用
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Western blot方法观察氯化钴诱导缺氧对 IGF-1R基因敲除HepG2肝癌细胞
IGF-1R、HIF-1α、VEGF蛋白表达的影响。结果表明，随着浓度的增加或作用
时间的延长，细胞生存活力受到明显抑制，CoCl2对IGF-1R基因敲除HepG2肝癌
细胞毒性作用就越大；随着CoCl2浓度和时间逐渐增加，HIF-1α和VEGF 蛋白
表达与IGF-1R基因敲除HepG2细胞缺氧存在明显的量效和时效关系，并且HIF-1
α与VEGF蛋白表达在缺氧诱导量效和时效关系中均存在显著的正相关性，说明
缺氧可以通过IGF-1R通路以外的途径诱导HIF-1α和VEGF 蛋白的表达。 
为了明确姜黄素是否经IGF-1R通路抑制缺氧HepG2肝癌细胞VEGF的表达，
我们以MTT比色法观察姜黄素对缺氧IGF-1R基因敲除HepG2肝癌细胞存活力的
影响，并将实验组分成以下4组：A组：缺氧；B组：缺氧+姜黄素；C组：IGF-1R 
KO+缺氧；D组：IGF-1R KO+缺氧+姜黄素，利用Western blot检测各组的IGF-1R、
p-Akt、Akt 、p-Erk1/2、Erk1/2、HIF-1α及VEGF蛋白的表达水平。结果表明，
姜黄素能抑制缺氧IGF-1R基因敲除HepG2肝癌细胞的增殖，并呈时间-剂量依赖
性；与A组：缺氧相比，我们发现IGF-1R、p-Akt、p-Erk1/2、HIF-1α及VEGF蛋
白相对表达量在B组：缺氧+姜黄素中明显降低，差异有统计学意义（P＜0.05），
这提示姜黄素可能通过IGF-1R通路抑制缺氧HepG2肝癌细胞HIF-1α及VEGF蛋
白的表达。继而，A组与B组的差值明显大于C组与D组的差值，具有统计学意义
（P＜0.01），这说明相对于缺氧HepG2细胞，姜黄素对缺氧IGF-1R基因敲除
HepG2细胞HIF-1α及VEGF蛋白表达的影响明显降低。结合A组与B组的对比结
果，我们得出姜黄素能通过IGF-1R通路抑制缺氧HepG2肝癌细胞HIF-1α及VEGF
蛋白表达。此外，与C组：IGF-1R KO+缺氧相比，我们也发现p-Akt、p-Erk1/2、
HIF-1α及VEGF蛋白相对表达量在D组IGF-1R KO+缺氧+姜黄素降低，差异有统
计学意义（P＜0.05），这说明姜黄素还可以通过其他信号通路抑制缺氧 HepG2
细胞HIF-1α及VEGF蛋白表达。 
总之，本实验证实姜黄素可通过IGF-1R信号通路抑制缺氧HepG2细胞HIF-1α
及VEGF蛋白的表达，而且还可通过其他信号途径起类似作用，其机制有待进一
步研究。本实验的研究结果将对姜黄素对肝癌的治疗及预防起一定的推动作用。 
关键词： HepG2肝癌细胞；IGF-1R基因敲除；CRISPR-Cas9；姜黄素；缺氧；
缺氧诱导因子-1α；血管内皮生长因子
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 Abstract 
Hepatocellular carcinoma(HCC) is one of the most common malignant tumor in the 
world, which is highly malignant and rich in blood supply, grew rapidly and conceal 
onset. As a solid tumor with lots of blood vessels，the main characteristic of HCC is 
the uncontrolled cancer cell proliferation, which brings about a hypoxia 
microenvironment in the tumor, thus promotes the angiogenesis. 
Curcumin (diferuloylmethane), extracted from the rhizome of the plant perennial 
herb Curcuma longa, is a liposoluble polyphenol pigment. Curcumin has a widespread 
pharmacological action, including antioxidant, anti-inflammation, anticoagulation, fat 
loss, anti-atherosclerosis, anti-neoplasm, anti-angiogenesis, liver protection, 
anti-aging, etc. Having advantages of extensive anti-neoplasm spectrum, 
little side-effect and low price makes curcumin the hot issue in recent research. 
However, the mechanism of the anti-angiogenesis for curcumin is 
clarified  incompletely which is worth studying.  
The cell signaling pathway plays an important role in the occur and development 
progress of neoplasm. The research, done by our laboratory group,  has shown 
a positive correlation between the IGF-1R pathway and expression of VEGF in 
hypoxia-induced HepG2 cells. The purpose of the present study is to confirm whether 
the curcumin inhibited VEGF expression via IGF-1R pathway in hypoxia-induced 
HepG2 cells.  
We constructed IGF-1R knockout HepG2 cell based on CRISPR/Cas9 technology 
simply and efficiently。MTT assay was used to observe the influence of IGF-1R 
knockout on HepG2 cells vitality, and curcumin on IGF-1R knockout HepG2 cells 
and HepG2 cells vitality. The results indicated, compared with HepG2 cells, IGF-1R 
knockout HepG2 cells proliferation was inhibited. And curcumin  has 
a greater inhibitive effect on IGF-1R knockout HepG2 cells than HepG2 cells.   
To observe the effect of IGF-1R knockout HepG2 cells vitality and IGF-1R, HIF-1
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α, VEGF expressions induced by hypoxia. We set up the hypoxia model using the 
cobalt chloride (CoCl2), and MTT assay was used to observe the influence of hypoxia 
on IGF-1R knockout HepG2 cells vitality. Western-blot assay was used to detect the 
IGF-1R, HIF-1α, VEGF protein expressions. The results showed that CoCl2 induced 
IGF-1R knockout HepG2 cells anoxic in a dose- and time-dependent manner , the 
cytotoxicity increased along with the time of culture 
and  the increase of doses of CoCl2. The HIF-1α protein had significant positive 
correlations with the VEGF protein expressions in a dose- and time-dependent manner, 
which indicated that hypoxia could induced the HIF-1 α and VEGF protein 
expressions via other pathways. 
To make sure whether curcumin inhibited the VEGF expression via IGF-1R 
pathway in hypoxia-induced IGF-1R knockout HepG2 cells. The influence of 
curcumin on cell survival in hypoxia-induced IGF-1R knockout HepG2 cells was 
accomplished by MTT assay. Western-blot was used to detect the IGF-1R, P-Akt, 
P-Erk1/2, HIF-1α  and VEGF protein expressions. The results suggested that 
curcumin inhibited hypoxia-induced IGF-1R knockout HepG2 cells vitality in 
a dose- and time-dependent manner. Curcumin can inhibit the HIF-1αand VEGF 
protein expression in hypoxia-induced HepG2 cells via IGF-1R pathway and other 
pathways. 
In summary, our research proved that curcumin can can inhibit VEGF expression in 
hypoxia-induced HepG2 cells not only via IGF-1R pathway, but also other pathways, 
which need further study. The results would improve the treatment and prevention of 
curcumin on liver cancer. 
Key words: HepG2 cell; IGF-1R knockout; CRISPR-Cas9; Curcumin; hypoxia; 
HIF-1α; VEGF 
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缩 略 词 表 
英文缩写 英文全称 中文全称 
HCC 
VEGF 
HIF-1        
EPO 
HO-1 
iNOS 
TACE 
 
HRE 
Hepatocellular carcinoma  
Vascular endothelial growth factor 
hypoxia-induciblefactor-1 
Erythropoietin  
Heme Oxygenase-1 
Incucible Nitric Oxide Sythase 
Transcatheter arterial 
chernoembolization 
Hypoxia-responsive element 
肝细胞性肝癌 
血管内皮因子 
缺氧诱导因子-1 
促红细胞生成素 
血红素氧合酶 
诱导一氧化氮合酶 
经动脉灌注化疗栓塞术 
 
缺氧反应原件 
TAVE 
 
bFGF  
PDGF  
TGFβ 
IL-8 
PIGF 
IKK 
Cur 
IFN-γ 
TNF-α 
LOX  
COX  
AP-1 
Ang-1/2 
PI3K 
transcatheter arterial and portal vein 
embolization 
basic fibroblast growth factor  
platelet-derived growth factor 
transforming growth factor-β 
interleukin-8 
placental-like growth factor  
IκB kinase  
Curcumin 
Interferon-γ 
tumor necrosis factor α 
Lipoxidase 
cyclooxygenase  
Activator protein-1 
Angiotensin-1/2 
phosphatidyl inositol 3-kinase 
经导管肝动脉联合门静
脉栓塞 
碱性成纤维生长因子 
血小板源性生长因子 
转化生长因子β 
白细胞介素-8 
胎盘样生长因子 
IκB 激酶复合体 
姜黄素 
抑制干扰素γ 
肿瘤坏死因子α 
脂肪氧化酶 
环氧合酶 
激活蛋白-1 
血管紧张素 1/2 
磷脂酰肌醇 3 激酶 
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英文缩写 英文全称 中文全称 
Akt 
MAPK 
Erk1/2       
DSB 
NHEJ 
HDR 
CRISPR 
 
ZFNs 
TALENs 
 
sgRNA 
CASCAD 
protein kinase B  
mitogen-activated protein kinases 
extracellular regulated protein kinases 
double stranded break  
non-homologous end joining 
homology directed repair 
clustered regularly interspaced short 
palindromic repeats 
Zinc-finger endonuclease 
transcription activator-like effector 
nuclease 
single-guide RNA 
CRISPR associated complex for 
antivirus defense 
 
蛋白激酶 B 
丝裂原活化激酶 
细胞外调节蛋白激酶 
DNA 双链断裂 
非同源末端连接 
同源重组 
规律成簇间隔短小回文
重复序列 
锌指核酸内切酶 
类转录激活因子效应物
核酸酶 
单导向 RNA 
CRISPR 相关的病毒防御
复合体 
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1 
前 言 
肝细胞性肝癌（hepatocellular carcinoma, HCC），是世界上最常见的恶性肿
瘤之一，具有高度恶性、血供丰富、生长迅速、化疗耐药及起病相对隐匿等特点
[1, 2]。据统计，在所有的恶性肿瘤中，HCC 的发病率排第 5 位，并且在肿瘤相关
性死亡的病因中排第 3 位，在中国甚至高居第 2 位[3-5]。由于肝炎病毒感染相对
严重，亚洲和非洲地区的发病率明显高于其他洲，而且发病率仍然在逐年剧增。
尽管外科手术和传统化疗水平的不断提高，但是 HCC 被诊断发现时大多有肝硬
化，已是癌症中晚期，总体生存率依然较低。因此，迫切需要新的更有效的肝癌
治疗方法。HCC 为富血管实体瘤，其最主要的特征是肿瘤细胞失控性生长，不
断增多的肿瘤细胞使耗氧量增加，从而导致肿瘤内缺氧微环境的形成。它将促进
血管内皮生长因子(vascular endothelial growth factor, VEGF)等相关促血管生成因
子的表达，这与肝癌的生长、浸润、转移、复发及预后密切相关[6]。为此，肿瘤
靶向治疗尤其是抗肿瘤血管生成治疗，成为肝癌缺氧治疗研究的新热点。 
一、肿瘤缺氧后血管形成的研究 
在肿瘤发生发展过程中,当肿瘤细胞增长速度超过血管生成的速度而导致缺
氧微环境的形成，为了继续生长，肿瘤细胞启动级联的缺氧适应性反应，其中最
主要的是缺氧诱导因子-1（hypoxia-inducible factor, HIF-1），失控的增殖导致肿瘤
内缺氧是 HCC 形成的特征性微环境。再者,目前经肝动脉化疗栓塞（TACE）是
治疗中晚期 HCC 非手术治疗最重要的方法。TACE 可以明显降低肿瘤负荷，延
长患者生存期，提高不能切除的 HCC 患者生活质量，大幅度改善预后。但是，
TACE 也有其缺点和局限性。单纯 TACE 治疗后 HCC 既因缺血缺氧和化疗药物
的细胞毒作用引起 HCC 细胞坏死,但仅选择性阻断肝动脉，HCC 仍然可以通过
门静脉获得部分血供, 也可通过肝周韧带或与周围组织粘连而获得侧支血供，或
通过因缺氧诱发 HCC 分泌 HIF-1,促进肿瘤血管生成，导致肿瘤复发和转移[7]。
厦
门
大
学
博
硕
士
论
文
摘
要
库
  
 
Degree papers are in the “Xiamen University Electronic Theses and 
Dissertations Database”.  
Fulltexts are available in the following ways: 
1. If your library is a CALIS member libraries, please log on 
http://etd.calis.edu.cn/ and submit requests online, or consult the interlibrary 
loan department in your library. 
2. For users of non-CALIS member libraries, please mail to etd@xmu.edu.cn 
for delivery details. 
厦
门
大
学
博
硕
士
论
文
摘
要
库
